Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on COUNTRYWIDE PLC. We currently have 4 research reports from 2 professional analysts.
|19Jan17 03:46||RNS||Holding(s) in Company|
|18Jan17 12:30||RNS||Holding(s) in Company|
|16Jan17 11:15||RNS||Holding(s) in Company|
|13Jan17 07:00||RNS||Trading Statement|
|11Jan17 10:14||RNS||Appointment of Joint Corporate Broker|
|06Jan17 04:31||RNS||Director/PDMR Shareholding|
|05Jan17 10:45||RNS||Block listing Interim Review|
Frequency of research reports
Research reports on
Chill for agents, spring in housing volumes
24 Nov 16
Yesterday’s Autumn Statement appears to be: good for 'alternative' housing providers, UK-focused contractors and materials producers; potentially problematic for mainstream housebuilders; and bad news especially for lettings-dominated agents. Chancellor Philip Hammond’s key spending measures included an additional £3.7bn funding to boost new housing volumes and £1.1bn for roads. Shares in estate agents, however, have fallen in response to the threat to ban them from charging fees to tenants.
Panmure Morning Note 31-07-15
31 Jul 15
We have made further cuts to earnings and dividend estimates partly on the back of the disappointing interim figures and also to reflect higher costs and depreciation charges given the ambitious plans announced to double the business over the period to 2020. While the shares have sold off 4%, lower earnings estimates leaves them trading on a full PE of 14x for the current year. We remain on a hold with a 570 target.
Panmure Morning Note 30-07-15
30 Jul 15
First half PBT of £28.9m was below expectations. Transaction volumes fell by 12% as H1 was adversely affected by the election. The outlook for the housing looks better for the second half though affordability is an increasing issue. We have already taken our FY15 forecasts down in anticipation. The current year PE is 13.8x. We are retaining our hold recommendation and 570p target.
Panmure Morning Note 16-07-15
16 Jul 15
Assuming lower interim profits owing to the election impact, we have cut our forecasts for FY15 by 7% bringing them close to consensus. If there is a strong enough rebound in the second half this may be conservative. The shares are down 10% in the last month and trade on 11.9x FY16 revised earnings. We retain our Hold recommendation and 570p price target given the favourable longer term outlook for the housing market.
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
N+1 Singer - Morning Song 16-01-2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare